Jason B. Daly, EVP, Chief Legal Officer at Amneal Pharmaceuticals, Inc. (AMRX), sold 180,000 shares at $8.88 ($1.6M) on 2025-03-05, disclosed to the SEC on 2025-03-07.
Open-market sale of $1.6M AMRX by EVP, Chief Legal Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.88 | 43,064 | $382K | 24.1% |
| 2 | $8.88 | 43,064 | $382K | 24.1% |
| 3 | $8.73 | 46,936 | $410K | 25.9% |
| 4 | $8.73 | 46,936 | $410K | 25.9% |
| Total | $8.80 avg | 180,000 | $1.6M | 100% |
| Filing → |
| AMRX | SELL | 2024-11-22 | $115K | — | Filing → |
| AMRX | SELL | 2024-11-19 | $752K | — | Filing → |